DBV Technologies (DBVT) Net Cash Flow Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -163.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -163.90% |
| Mar 31, 2026 | 296.52% |
| Dec 31, 2025 | 1,242.17% |
| Sep 30, 2025 | -44.24% |
| Jun 30, 2025 | 341.46% |
| Mar 31, 2025 | 45.51% |
| Dec 31, 2024 | 23.31% |
| Sep 30, 2024 | -8.81% |
| Jun 30, 2024 | -90.27% |
| Mar 31, 2024 | -77.23% |
| Dec 31, 2023 | 41.90% |
| Sep 30, 2023 | -0.09% |
| Jun 30, 2023 | -109.78% |
| Mar 31, 2023 | -1,200.00% |
| Dec 31, 2022 | -28.14% |
| Sep 30, 2022 | 13.94% |
| Jun 30, 2022 | 726.77% |
| Mar 31, 2022 | 95.55% |
| Dec 31, 2021 | 44.84% |
| Sep 30, 2021 | 45.37% |